Calprotectin (S100A8/A9) has been identified as a biomarker that can aid in predicting the severity of disease in COVID‐19 patients. This study aims to evaluate the correlation between levels of… Click to show full abstract
Calprotectin (S100A8/A9) has been identified as a biomarker that can aid in predicting the severity of disease in COVID‐19 patients. This study aims to evaluate the correlation between levels of circulating calprotectin (cCP) and the severity of COVID‐19.
               
Click one of the above tabs to view related content.